Interim Report on the Safety and Efficacy of Longer-term Treatment with Nusinersen in Infantile-onset Spinal Muscular Atrophy (SMA): Updated Results from the SHINE Study

被引：0
|
作者：
Finkel, R.
Castro, D.
Farrar, M.
Tulinius, M.
Krosschell, K.
Saito, K.
Reyna, S.
Zhang, Y.
Bhan, I
Wong, J.
Farwell, W.
机构：
来源：
ANNALS OF NEUROLOGY | 2019年 / 86卷
关键词：
Neuromuscular Disorders; Rare Diseases;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
174
引用
收藏
页码：S122 / S123
页数：2
相关论文
共 50 条
  • [31] Nusinersen in Infants Who Initiate Treatment in a Presymptomatic Stage of Spinal Muscular Atrophy (SMA): Interim Results From the Phase 2 NURTURE Study
    Finkel, Richard S.
    De Vivo, Darryl C.
    Swoboda, Kathryn J.
    Bertini, Enrico
    Hwu, Wuh-Liang
    Foster, Richard
    Bhan, Ishir
    Fradette, Stephanie
    Farwell, Wildon
    NEUROLOGY, 2020, 94 (15)
  • [32] Interim results from RESPOND: a study of nusinersen in children with spinal muscular atrophy (SMA) previously treated with onasemnogene abeparvovec (OA)
    Masson, R.
    Proud, C.
    Finkel, R.
    Parsons, J.
    Kuntz, N.
    Foster, R.
    Li, W.
    Chary, S.
    Sohn, J.
    Fradette, S.
    Youn, B.
    Paradis, A.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [33] Nusinersen in Infants Diagnosed with Spinal Muscular Atrophy (SMA): Study Design and Initial Interim Efficacy and Safety Findings from the Phase 3 International ENDEAR Study
    Kuntz, Nancy
    Farwell, Wildon
    John, Zhenshao
    Sun, Zhong Peng
    Gheuens, Sarah
    Schneider, Eugene
    Finkel, Richard
    NEUROLOGY, 2017, 88
  • [34] A CAUTIONARY TALE FOR INDIRECT TREATMENT COMPARISONS: AN EXAMPLE FROM INFANTILE-ONSET SPINAL MUSCULAR ATROPHY
    Liao, S.
    Bohn, J.
    de Moor, C.
    Valente, M.
    Xaplanteris, L.
    Farwell, W.
    Paradis, A. D.
    VALUE IN HEALTH, 2020, 23 : S709 - S709
  • [35] Motor Function Change Over Time Among Nusinersen-Treated Participants with Infantile-onset Spinal Muscular Atrophy (SMA) in the ENDEAR-SHINE Study Who Met the Permanent Ventilation (PV) Definition
    Castro, D.
    Wong, J.
    Kandinov, B.
    Foster, R.
    Paradis, A.
    Joluison, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 356 - 356
  • [36] Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
    De Vivo, Darryl C.
    Bertini, Enrico
    Swoboda, Kathryn J.
    Hwu, Wuh-Liang
    Crawford, Thomas O.
    Finkel, Richard S.
    Kirschner, Janbernd
    Kuntz, Nancy L.
    Parsons, Julie A.
    Ryan, Monique M.
    Butterfield, Russell J.
    Topaloglu, Haluk
    Ben-Omran, Tawfeg
    Sansone, Valeria A.
    Jong, Yuh-Jyh
    Shu, Francy
    Staropoli, John F.
    Kerr, Douglas
    Sandrock, Alfred W.
    Stebbins, Christopher
    Petrillo, Marco
    Braley, Gabriel
    Johnson, Kristina
    Foster, Richard
    Gheuens, Sarah
    Bhan, Ishir
    Reyna, Sandra P.
    Fradette, Stephanie
    Farwell, Wildon
    NEUROMUSCULAR DISORDERS, 2019, 29 (11) : 842 - 856
  • [37] Longer-term Experience with Nusinersen in Teenagers and Young Adults with Spinal Muscular Atrophy: Phosphorylated Neurofilament Heavy Chain (pNF-H) and Efficacy Results From the CS2-12/SHINE Studies
    Muntoni, F.
    Darras, B. T.
    Finkel, R. S.
    Ryan, M. M.
    Mercuri, E.
    Tulinius, M.
    Deconinck, N.
    Ramirez-Schrempp, D.
    Foster, R.
    Liu, Y.
    Petrillo, M.
    Wong, J.
    Kandinov, B.
    Farwell, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 948 - 949
  • [38] Exploring possible predictors of clinical outcomes following nusinersen treatment of Spinal Muscular Atrophy (SMA): interim results from the Phase 2 NURTURE Study
    Sansone, V. A.
    Kirschner, J.
    De Vivo, D. C.
    Bertini, E.
    Hwu, W. L.
    Foster, R.
    Ramirez-Schrempp, D.
    Fradette, S.
    Chin, R.
    Farwell, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 9 - 9
  • [39] One-year Outcomes Following Treatment with Nusinersen: Interim Results from the NURTURE Study of Presymptomatic Infants with Genetically Diagnosed Spinal Muscular Atrophy (SMA)
    De Vivo, D.
    Bertini, E.
    Hwu, W-L
    Foster, R.
    Gheuens, S.
    Farwell, W.
    Reyna, S.
    ANNALS OF NEUROLOGY, 2017, 82 : S265 - S266
  • [40] Safety and Efficacy of Nusinersen in Infants/Children with Spinal Muscular Atrophy (SMA): Part 1 of the Phase 2 EMBRACE Study
    Shieh, Perry B.
    Acsadi, Gyula
    Mueller-Felber, Wolfgang
    Crawford, Thomas O.
    Richardson, Randal
    Natarajan, Nina
    Castro, Diana
    Gheuens, Sarah
    Bhan, Ishir
    Gambino, Giulia
    Sun, Peng
    Farwell, Wildon
    Reyna, Sandra P.
    NEUROLOGY, 2018, 90
12345